Skip to main content
Fig. 6 | BMC Immunology

Fig. 6

From: Integrated bulk RNA sequencing and mass cytometry analysis reveal the circulating immune landscape in ischemic and hemorrhagic Moyamoya disease

Fig. 6

Overview of imaging mass cytometry on B cells in ischemic and hemorrhagic MMD patients. (A) Representative t-SNE plot of five B cell clusters from MMD patients. (B) t-SNE heatmap of cluster markers. (C) Donut chart showing B cell subset proportions in ischemic and hemorrhagic MMD patients. (D) Bar chart comparing B cell subset proportions between ischemic and hemorrhagic groups. (E) Heatmap showing protein expression levels across B cell clusters. (F) Molecular expression in B03 cluster. (G) Expression differences of ERK between ischemic and hemorrhagic groups in B cell clusters. Significance: ns, p ≥ 0.05; *p < 0.05; **p < 0.01

Back to article page